PLSM
Pulsenmore Ltd. Ordinary Shares
NASDAQ · Healthcare · Medical - Devices · IL
$2.45
−2.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 52.5M | 40.0M | 9.6M | 6.1M | 10.6M |
| Cost of Revenue | 14.2M | 6.3M | 7.6M | 6.1M | 6.7M |
| Gross Profit | 38.3M | 33.7M | 2.1M | 39.7K | 3.9M |
| Operating Expenses | |||||
| R&D Expense | 43.0M | 17.4M | 18.9M | 30.1M | 28.3M |
| SG&A Expense | 54.0M | 10.6M | 34.0M | 32.6M | 29.3M |
| General & Admin Expense | 9.3M | 5.5M | 17.2M | 19.0M | 16.8M |
| Selling & Marketing Expense | 5.1M | 5.1M | 16.8M | 13.6M | 12.6M |
| Other Expenses | 10.0M | 17.9M | (8.7M) | (7.5M) | (8.5M) |
| Total Operating Expenses | 107.0M | 45.8M | 44.2M | 55.2M | 49.1M |
| Cost and Expenses | 121.2M | 52.2M | 51.8M | 61.2M | 55.8M |
| Operating Income (EBIT) | (68.7M) | (12.2M) | (42.1M) | (55.1M) | (45.3M) |
| Non-Operating | |||||
| Interest Income | 11.0M | 3.5M | 5.3M | 6.8M | 3.0M |
| Interest Expense | 4.3M | 315.0K | 538.8K | 605.8K | 341.8K |
| Net Interest Income | 6.7M | 3.2M | 4.8M | 6.2M | 2.7M |
| Other Non-Op Income/Expense | (57.9K) | (3.7M) | 5.4M | (2.8M) | 23.6M |
| Non-Operating Income (excl Interest) | (4.3M) | 3.4M | (5.9M) | 2.2M | (23.9M) |
| EBT (Pre-Tax Income) | (68.8M) | (15.9M) | (36.7M) | (57.9M) | (21.7M) |
| Income Tax Expense | (54.2K) | 1.0K | (55.9K) | 125.9K | — |
| Bottom Line | |||||
| Net Income | (68.7M) | (15.9M) | (36.7M) | (58.1M) | (21.7M) |
| Earnings from Cont. Ops | (68.7M) | (15.9M) | (36.7M) | (58.1M) | (21.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (68.7M) | (15.9M) | (36.7M) | (58.1M) | (21.7M) |
| Per Share | |||||
| Basic EPS | ($10.83) | ($2.47) | ($5.71) | ($9.07) | ($3.58) |
| Diluted EPS | ($10.83) | ($2.47) | ($5.71) | ($9.07) | ($3.58) |
| Revenue Per Share | $8.16 | $6.23 | $1.51 | $0.96 | $1.76 |
| Shares | |||||
| Basic Shares Outstanding | 6.4M | 6.4M | 6.4M | 6.4M | 6.0M |
| Diluted Shares Outstanding | 6.4M | 6.4M | 6.4M | 6.4M | 6.0M |
| Profitability Metrics | |||||
| EBITDA | (57.8M) | (12.7M) | (33.3M) | (55.0M) | (20.1M) |
| D&A | 6.7M | 2.8M | 2.8M | 2.4M | 1.3M |
| EBIT | (64.4M) | (15.5M) | (36.2M) | (57.3M) | (21.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025